通过检查点降解合抗原呈现进行内疫苗接种
Yu Han1,2,3, Yicong Ma2,3, Miao Pei1
1Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, China.
Nature
|January 7, 2026
概括
研究人员开发了一种瘤内接种模拟疫苗 (iVAC),将瘤细胞重新编程成抗原呈现细胞,恢复抗瘤免疫力. 这种新的方法增强了T细胞的活性,并促进了持续的瘤特异性免疫力.
科学领域:
- 癌症学
- 免疫学
- 生物技术
背景情况:
- 抗原呈现细胞的交叉呈现减少导致缺乏瘤反应性T细胞.
- 恢复瘤微环境中的T细胞功能对于有效的癌症免疫疗法至关重要.
研究的目的:
- 通过重新编程瘤细胞来开发一种新的T细胞复原策略.
- 为恢复抗瘤免疫而设计一种内疫苗化体 (iVAC).
主要方法:
- 通过将PD-L1降解剂与免疫抗原结合而形成IVAC仿真体.
- 通过内注射IVAC将瘤细胞重新编程成抗原呈现细胞 (APC).
- 在实验室,在人性化的小鼠模型和使用细胞巨病毒 (CMV) 衍生抗原的患者瘤模型中评估了IVAC的疗效.
主要成果:
- iVAC成功地将瘤细胞重新编程成类似APC的细胞,从而增强了抗原呈现.
- 这种重新编程导致通过对抗原特异性CD8+T细胞的重新激活来杀死瘤.
- 治疗重塑了瘤的微环境,促进了持续的瘤特异性免疫力.
结论:
- 化学重编程瘤细胞以表现出类似APC的功能是刺激抗瘤免疫力的可行策略.
- 通过增强瘤床内的T细胞反应, iVAC为癌症免疫治疗提供了一个有前途的新途径.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Vaccinations
51.2K
Overview
51.2K
Cancer Vaccines
946
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
946
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Antigen Processing Pathways
2.1K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
2.1K
Antigen Presenting Cells
2.9K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
2.9K


